BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/27/2019 10:40:37 AM | Browse: 1080 | Download: 2861
 |
Received |
|
2019-05-08 03:56 |
|
Peer-Review Started |
|
2019-05-10 01:16 |
|
First Decision by Editorial Office Director |
|
2019-05-30 15:59 |
|
Return for Revision |
|
2019-06-03 03:18 |
|
Revised |
|
2019-06-09 02:07 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-06-14 08:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-06-17 20:21 |
|
Articles in Press |
|
2019-06-17 20:21 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-06-27 08:18 |
|
Publish the Manuscript Online |
|
2019-06-27 10:40 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shinya Nishida, Koichi Hamada, Noriyuki Nishino, Daizo Fukushima, Ryota Koyanagi, Yoshinori Horikawa, Yoshiki Shiwa and Satoshi Saitoh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Koichi Hamada, MD, Doctor, Doctor, Department of Gastroenterology, Southern-Tohoku General Hospital, 7-115, Yatsuyamada, Koriyama 963-8563, Japan. koichi.hamada@mt.strins.or.jp |
| Key Words |
Hepatic encephalopathy; Rifaximin; Hepatic cirrhosis; Spontaneous portosystemic shunt; Magnetic resonance elastography; Child-Pugh classification |
| Core Tip |
This study evaluated the efficacy and safety of long-term rifaximin therapy for hepatic encephalopathy in the Japanese population. Serum ammonia level was maintained at a significantly low median value of 80.5 μg/dL (range, 44-150 μg/dL) at 24 wk after treatment, and the long-term use of rifaximin did not worsen liver function. |
| Publish Date |
2019-06-27 10:40 |
| Citation |
Nishida S, Hamada K, Nishino N, Fukushima D, Koyanagi R, Horikawa Y, Shiwa Y, Saitoh S. Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese World J Hepatol 2019; 11(6): 531-541
|
| URL |
https://www.wjgnet.com/1948-5182/full/v11/i6/531.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v11.i6.531 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
